Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2C | P28335 | 3/20 | 0.41 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.36 |
| ▸ | CHRM2 | P08172 | 4/20 | 0.35 |
| ▸ | CHRM5 | P08912 | 4/20 | 0.35 |
| ▸ | CHRM3 | P20309 | 4/20 | 0.35 |
| ▸ | CHRM4 | P08173 | 3/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.35 |
| ▸ | HTR2A | P28223 | 1/20 | 0.35 |
| ▸ | HTR2B | P41595 | 1/20 | 0.35 |
| ▸ | KDM1A | O60341 | 1/20 | 0.33 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.33 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11138422 | 0.90 | HTR2C (0.43) | HTR2CTAAR1HTR2AHTR2BKDM1A | |
| SCHEMBL29748038 | 0.90 | HTR2C (0.43) | HTR2CTAAR1HTR2AHTR2BKDM1A | |
| SCHEMBL31444339 | 0.81 | TP53 (0.37) | HTR2CTAAR1CHRM2CHRM5CHRM3 | |
| SCHEMBL21491215 | 0.81 | TP53 (0.37) | HTR2CTAAR1CHRM2CHRM5CHRM3 | |
| Trifluoroacetic Acid SCHEMBL14839980 | 0.78 | PRCP (0.39) | HTR2CKDM1A | |
| SCHEMBL23323100 | 0.78 | HTR2C (0.52) | HTR2CTAAR1CHRM2CHRM5CHRM3 | |
| SCHEMBL3331668 | 0.78 | HTR2C (0.52) | HTR2CTAAR1CHRM2CHRM5CHRM3 | |
| SCHEMBL29941194 | 0.78 | HTR2C (0.52) | HTR2CTAAR1CHRM2CHRM5CHRM3 | |
| SCHEMBL31444509 | 0.78 | HTR2C (0.52) | HTR2CTAAR1CHRM2CHRM5CHRM3 | |
| SCHEMBL29747537 | 0.78 | HTR2C (0.52) | HTR2CTAAR1CHRM2CHRM5CHRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022140224-A1 | 1H-PYRROLO[2,3-B]PYRIDINE DERIVATIVES AS BCL-2 INHIBITORS FOR THE TREATMENT OF NEOPLASTIC AND AUTOIMMUNE DISEASES | NEWAVE PHARMACEUTICAL INC. (US) | 2022-06-30 | — | — | WO | disclosed |